FDA Inspection 1119867 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on February 24, 2020 in Santa Ana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 24, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Santa Ana, CA (United States)